Roger Ying
Overview
Explore the profile of Roger Ying including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahu M, Bayer C, Roberts D, van Rooyen H, van Heerden A, Shahmanesh M, et al.
PLOS Glob Public Health
. 2023 Sep;
3(9):e0000610.
PMID: 37669249
Community-based delivery and monitoring of antiretroviral therapy (ART) for HIV has the potential to increase viral suppression for individual- and population-level health benefits. However, the cost-effectiveness and budget impact are...
2.
Ying R, Fekadu L, Schackman B, Verguet S
Trop Med Int Health
. 2019 Dec;
25(3):301-307.
PMID: 31808592
Objectives: Ethiopia's HIV prevalence has decreased by 75% in the past 20 years with the implementation of antiretroviral therapy, but HIV transmission continues in high-risk clusters. Identifying the spatial and...
3.
Ross J, Ying R, Celum C, Baeten J, Thomas K, Murnane P, et al.
Epidemics
. 2017 Dec;
23:34-41.
PMID: 29223580
Introduction: Mathematical models that incorporate HIV disease progression dynamics can estimate the potential impact of strategies that delay HIV disease progression and reduce infectiousness for persons not on antiretroviral therapy...
4.
Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya
Sharma M, Smith J, Farquhar C, Ying R, Cherutich P, Golden M, et al.
AIDS
. 2017 Nov;
32(2):233-241.
PMID: 29135576
Background: Assisted partner services (aPS) or provider notification for sexual partners of persons diagnosed HIV positive can increase HIV testing and linkage in Sub-Saharan Africa and is a high yield...
5.
Sharma M, Farquhar C, Ying R, Krakowiak D, Kinuthia J, Osoti A, et al.
J Acquir Immune Defic Syndr
. 2016 Jun;
72 Suppl 2:S174-80.
PMID: 27355506
Introduction: Women in sub-Saharan Africa face a 2-fold higher risk of HIV acquisition during pregnancy and postpartum and the majority do not know the HIV status of their male partner....
6.
Ying R, Sharma M, Celum C, Baeten J, van Rooyen H, Hughes J, et al.
Lancet HIV
. 2016 Jun;
3(6):e275-82.
PMID: 27240790
Background: Home HIV testing and counselling (HTC) achieves high levels of HIV testing and linkage to care. Periodic home HTC, particularly targeted to those with high HIV viral load, might...
7.
Ying R, Granich R, Gupta S, Williams B
Clin Infect Dis
. 2016 Jan;
62(8):1022-8.
PMID: 26826372
Antiretroviral therapy (ART) policy for people living with human immunodeficiency virus (HIV) has historically been based on clinical indications, such as opportunistic infections and CD4 cell counts. Studies suggest that...
8.
Sharma M, Ying R, Tarr G, Barnabas R
Nature
. 2015 Dec;
528(7580):S77-85.
PMID: 26633769
HIV testing and counselling is the first crucial step for linkage to HIV treatment and prevention. However, despite high HIV burden in sub-Saharan Africa, testing coverage is low, particularly among...
9.
Khanna A, Roberts S, Cassels S, Ying R, John-Stewart G, Goodreau S, et al.
PLoS One
. 2015 Aug;
10(8):e0134271.
PMID: 26262889
Introduction: Prevention of mother-to-child HIV transmission (PMTCT) strategies include combined short-course antiretrovirals during pregnancy (Option A), triple-drug antiretroviral treament (ART) during pregnancy and breastfeeding (Option B), or lifelong ART (Option...
10.
Ying R, Sharma M, Heffron R, Celum C, Baeten J, Katabira E, et al.
J Int AIDS Soc
. 2015 Jul;
18(4 Suppl 3):20013.
PMID: 26198348
Introduction: Despite scale-up of antiretroviral therapy (ART) for treating HIV-positive persons, HIV incidence remains elevated among those at high risk such as persons in serodiscordant partnerships. Antiretrovirals taken by HIV-negative...